Skip to main content
. 2022 Oct 18;20:345. doi: 10.1186/s12957-022-02796-8

Table 3.

Postoperative pathologic outcomes (overall cohort)

Variables Open
N=49
Laparoscopic
N=92
Robotic
N=70
P
Tumor location 0.067
 TC&SF, n (%) 14 (28.6%) 26 (28.3%) 16 (22.9%)
 UDC, n (%) 24 (49.0%) 29 (31.5%) 21 (30.0%)
 LDC, n (%) 11 (22.4%) 37 (40.2%) 33 (47.1%)
With adenomatous polyps, n (%) 11 (22.4%) 31 (33.7%) 14 (20.0%) 0.112
Neoplasm longest diameter (cm) 5.6±2.4 5.1±1.8 5.0±1.8 0.243§
Tumor differentiation 0.834
 Well, n (%) 3 (6.1%) 10 (10.9%) 8 (11.4%)
 Moderate, n (%) 36 (73.5%) 69 (75.0%) 54 (77.1%)
 Poor, n (%) 7 (14.3%) 8 (8.7%) 5 (7.1%)
 Mucinous, n (%) 3 (6.1%) 5 (5.4%) 3 (4.3%)
pTNM stage 0.261
 I, n (%) 5 (10.2%) 14 (15.2%) 15 (21.4%)
 II, n (%) 22 (44.9%) 45 (48.9%) 24 (34.3%)
 III, n (%) 22 (44.9%) 33 (35.9%) 31 (44.3%)
pT stage 0. 412
 T1, n (%) 2 (4.1%) 10 (10.9%) 10 (14.3%)
 T2, n (%) 4 (8.2%) 4 (4.3%) 5 (7.1%)
 T3, n (%) 6 (12.2%) 11 (12.0%) 4 (5.7%)
 T4a, n (%) 35 (75.5%) 62 (72.8%) 51 (72.9%)
pN stage 0.399
 N0, n (%) 27 (55.1%) 59 (64.1%) 39 (55.7%)
 N1, n (%) 13 (26.5%) 21 (22.8%) 24 (34.3%)
 N2, n (%) 9 (18.4%) 12 (13.0%) 7 (10.0%)
Number of lymph node harvest 14.7±6.2 14.0±6.0 14.0±4.8 0.725§
Positive resection margin, n (%) 0 (0.0%) 0 (0.0%) 0 (0.0%) /
With lymph node metastasis, n (%) 22 (44.9%) 32 (34.8%) 31 (44.3%) 0.358
With lymphovascular invasion, n (%) 11 (22.4%) 14 (15.2%) 10 (14.3%) 0.447
With extranodal tumor deposits, n (%) 6 (12.2%) 14 (15.2%) 13 (18.6%) 0.639
With perineural invasion, n (%) 17 (34.7%) 34 (37.0%) 24 (34.3%) 0.931

Values are expressed as mean (SD = standard deviation) or n (%)

Abbreviation: TC The distal 1/3 of the transverse colon, SF Splenic flexure, UDC Upper segment of descending colon, LDC Lower segment of descending colon, pTNM Pathological tumor-node-metastasis

§Kruskal-Wallis test

Pearson’s chi-squared test

Fisher’s exact test